Regulatory Disclosure. Under limited circumstances, we may disclose your personal information to third parties as permitted by, or required to comply with, Applicable Laws, Rules and/or Regulations in the jurisdiction of which you are a citizen or a permanent resident, or, in the case of a Legal Entity is formed, incorporated, domiciliation and/or doing business, and/or of the jurisdiction in which we are organized and/or is performing the Services provided hereunder. For example, we may disclose personal information to cooperate with regulatory authorities and law enforcement agencies to comply with subpoenas or other official requests, and as necessary to protect our rights or property. Except as described herein, we will not use your personal information for any other purpose, unless we describe how such information will be used at the time you disclose it to us, or we obtain your permission.
Regulatory Disclosure. Xxxxxxx Xxxxx Statham Investments Limited is authorised and regulated by the Financial Conduct Authority (FCA) and is bound by the applicable FCA rules outlined in its Handbook. The firm’s Financial Services Register number is 483868. The firm’s permitted business is arranging, advising, dealing as agent, and making arrangement for undertaking transactions in investments.
Regulatory Disclosure. The Issuer acknowledges, in connection with the purchase and sale of the Bonds, the offering of the Bonds for sale and the discussions and negotiations relating to the terms of the Bonds pursuant to and as set forth in this Agreement, that:
Regulatory Disclosure. The statements set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the caption “Supervision and Regulation,” insofar as such statements purport to describe laws and regulations specifically referred to therein, and subject to the qualifications, exceptions, assumptions and limitations described therein, are accurate, complete and fair in all material respects.
Regulatory Disclosure. (a) The Company agrees and gives consent to the disclosure by any Finance Party of all or any:
Regulatory Disclosure. The statements included in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the caption “Business—Government regulation and product approval” fairly summarize the matters described therein in all material respects and with respect to applicable laws of the FDA (or foreign equivalents) which as of the date hereof are material to the businesses of the Company and its subsidiaries.
Regulatory Disclosure. The statements included in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the captions “Risk factors – Risks related to government regulation” and “Business – Government regulation,” in each case, fairly summarize the matters described therein in all material respects.
Regulatory Disclosure. The statements incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the captions “Risk factors—Risks related to regulatory approval of our product candidates and other legal compliance matters” from the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2020 and “Business—Government regulation and product approvals” from the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, in each case, fairly summarize the matters described therein in all material respects.
Regulatory Disclosure. If a Receiving Party becomes legally compelled to disclose any Confidential Information (through court order, governmental requirement, or any legal procedure), the Receiving Party shall, if permitted: (a) promptly notify the Disclosing Party, allowing it to seek a protective order or other appropriate remedy; and (b) disclose only the portion of Confidential Information that it is legally required to, ensuring that confidential status is asserted where applicable. Additionally, a Receiving Party may disclose Confidential Information of the Disclosing Party to a governmental agency or regulatory authority with jurisdiction over it in response to a routine examination by such regulatory (including self-regulatory) authority or governmental agency.
Regulatory Disclosure. (a) Between the execution of this Agreement and the Closing Date, the Company and Parent shall cooperate with one another to evaluate each of the items set forth on Schedule 7.15(a) (the “Identified Matters”) for compliance with Healthcare Requirements. In the event that Parent determines in its sole discretion that a self-disclosure with respect to any or all of the Identified Matters to the Centers for Medicare and Medicaid Services (“CMS”), the OIG or other applicable Governmental Authority is required or is a prudent course of action, the Company shall cause the applicable Target Entity to take such action prior to the Closing; provided, however, that notwithstanding the foregoing, in the event the Company or such Target Entity determines that any of the Identified Matters may be appropriately resolved by a voluntary refund to the applicable Government Reimbursement Program(s) and Parent agrees with such determination, which agreement may be withheld in Parent’s sole and absolute discretion, the Company or such Target Entity may, in lieu of a self-disclosure, file a voluntary refund with respect to such violations or items with CMS, the OIG, the applicable Medicare Administrative Contractor or other applicable Governmental Authority prior to the Closing.
